PetIQ Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PetIQ stock.
View analyst ratings for PetIQ or view top-rated stocks.

Wall Street analysts have given PetIQ a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PetIQ wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

PetIQ is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for PetIQ.

PetIQ will be holding an earnings conference call on Wednesday, August 4th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13721933".

PetIQ, Inc. (NASDAQ:PETQ) released its quarterly earnings results on Wednesday, May, 5th. The company reported $0.39 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.35. The firm earned $254.35 million during the quarter, compared to analysts' expectations of $211.07 million. PetIQ had a positive trailing twelve-month return on equity of 5.10% and a negative net margin of 8.65%.
View PetIQ's earnings history.

PetIQ's stock was trading at $22.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ shares have increased by 59.4% and is now trading at $36.01.
View which stocks have been most impacted by COVID-19.

PetIQ issued an update on its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $950 million-$950 million, compared to the consensus revenue estimate of $938.13 million.

2 brokers have issued 12-month price targets for PetIQ's shares. Their forecasts range from $45.00 to $175.00. On average, they expect PetIQ's stock price to reach $90.00 in the next year. This suggests a possible upside of 149.9% from the stock's current price.
View analysts' price targets for PetIQ or view top-rated stocks among Wall Street analysts.

10 employees have rated PetIQ CEO Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among PetIQ's employees.

Some companies that are related to PetIQ include Nu Skin Enterprises (NUS), (BTCA) (BTCA), Trxade Group (TRXD), TRxADE HEALTH (MEDS), Bioasis Technologies (BIOAF), Medizone International (MZEIQ), China Medicine (CHME), Aceto (ACETQ), China BCT Pharmacy Group (CNBI) and ScripsAmerica (SCRCQ).
View all of PETQ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by a number of institutional and retail investors. Top institutional shareholders include TRH Financial LLC (0.10%) and Boyd Watterson Asset Management LLC OH (0.05%). Company insiders that own PetIQ stock include John Newland, Mark L First, Mccord Christensen, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ.

PETQ stock was sold by a variety of institutional investors in the last quarter, including TRH Financial LLC. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mark L First, Mccord Christensen, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, and Susan Sholtis.
View insider buying and selling activity for PetIQ or view top insider-selling stocks.

PETQ stock was bought by a variety of institutional investors in the last quarter, including Boyd Watterson Asset Management LLC OH. Company insiders that have bought PetIQ stock in the last two years include John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ or or view top insider-buying stocks.

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETQ stock can currently be purchased for approximately $36.01.

PetIQ has a market capitalization of $1.05 billion and generates $780.05 million in revenue each year. The company earns $-77,470,000.00 in net income (profit) each year or $0.30 on an earnings per share basis.

PetIQ employs 2,072 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ is headquartered at 923 S. Bridgeway Pl., EAGLE ID, 83616.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]